or random*.ti. or randomized controlled trial.pt. OR crossover*.mp. or cross over.mp. or ((singl* or doubl* or tripl* or trebl*) ADJ3 (blind* or mask* or sham*)).mp. or latin square.mp. or ISRTCN or ACTRN* or (NCT* not NCT) or (clinical trials/ and random*.ti.) Appendix K: Alternative Text Description of Algorithm The following outline narratively describes the Algorithm: Management of Dyslipidemia for Cardiovascular Risk Reduction. An explanation of the purpose of the algorithms and description of the various shapes used within the algorithms can be found in the Algorithm background section. The sidebars referenced within this outline can also be found in the Algorithm background section. Algorithm: Management of Dyslipidemia for Cardiovascular Risk Reduction 1. Module A begins with Box 1, in the shape of a rounded rectangle: Patient 40 years old (There are no evidence-based recommendations for patients under age 40 because there is no evidence for the benefit of lipid screening and treatment within this age group. In patients younger than 40 years old interested in pursuing lipid testing and management, shared decision making is recommended to discuss the risks and unknown benefit of pharmacotherapy, with therapeutic lifestyle changes being the primary focus of CVD primary prevention.) 2. Box 1 connects to Box 2, in the shape of a hexagon, asks the question: Does patient have HF with EF <35%, ESRD, or life expectancy <5 years? a. If the answer is Yes to Box 2, then Box 3, in the shape of an oval: Discuss lack of evidence demonstrating benefit and continue ongoing care b. If the answer is No to Box 2, then Box 4, in the shape of a hexagon, asks the question: Does patient have higher risk CVD? (see Sidebar 2) i. 